Diagnostics

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® TestProteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

CAMBRIDGE, United Kingdom, Oct. 9, 2024 /PRNewswire/ -- Proteotype Diagnostics Ltd, in collaboration with the University of Southampton, has been awarded…

8 months ago
XORTX Initiates Precision Medicine ProgramXORTX Initiates Precision Medicine Program

XORTX Initiates Precision Medicine Program

Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine MetabolismCALGARY, Alberta, Oct.…

8 months ago
Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical CareBeckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care

Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care

Alliance marks first penKid licensing agreement for high throughput immunoassay.Partnership leverages SphingoTec's proficiency in acute kidney injury testing,and Beckman Coulter's…

8 months ago
Velsera and Diagnostics Longwood Partner to Revolutionize Access to Precision Genomics for Patients in Spain and PortugalVelsera and Diagnostics Longwood Partner to Revolutionize Access to Precision Genomics for Patients in Spain and Portugal

Velsera and Diagnostics Longwood Partner to Revolutionize Access to Precision Genomics for Patients in Spain and Portugal

Announcing a Strategic Partnership to Enhance NGS Solutions in the Iberian Market LONDON, Oct. 8, 2024 /PRNewswire/ -- Velsera, a leading…

8 months ago
Axtria Showcases AI-Powered Innovations at PMSA 2024 Fall SymposiumAxtria Showcases AI-Powered Innovations at PMSA 2024 Fall Symposium

Axtria Showcases AI-Powered Innovations at PMSA 2024 Fall Symposium

Axtria showcases its collaboration with leading pharma companies on AI-driven insights, field force optimization, and data strategies. CHICAGO, Oct. 8,…

8 months ago
NanoViricides to Present at the Global AMR Summit 2024 TomorrowNanoViricides to Present at the Global AMR Summit 2024 Tomorrow

NanoViricides to Present at the Global AMR Summit 2024 Tomorrow

Dr. Diwan to Discuss "Shape-Shifting", "Trojan Horse", Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR SHELTON, CT /…

8 months ago
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical TrialOncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to…

8 months ago
Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New VersionMainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version

Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version

GANZIMMUN Diagnostics to Feature ColoAlert at the 57th Medizinische Woche Baden-BadenBERKELEY, Calif. and MAINZ, Germany, Oct. 08, 2024 (GLOBE NEWSWIRE)…

8 months ago
Commencement of trading on OTCQB in the United StatesCommencement of trading on OTCQB in the United States

Commencement of trading on OTCQB in the United States

Renalytix plc American Depository Shares (ADSs) begin trading on OTCQB Venture Market under symbol “RNLXY” effective from Market Open on October…

8 months ago